Secondary Versus Tertiary Wound Closure in High Risk Gynecologic Abdominal Surgical Incisions

Sponsor
Wake Forest University Health Sciences (Other)
Overall Status
Terminated
CT.gov ID
NCT03861065
Collaborator
National Cancer Institute (NCI) (NIH)
8
1
2
21
0.4

Study Details

Study Description

Brief Summary

The purpose of this research study is to determine if closing a surgical wound differently is better than the procedure that is currently used. The wound will be closed with what is considered "tertiary intent." This means, rather than leaving the wound open, the wound will be partially closed after surgery, and then completely closed 4-7 days after surgery. The investigators also want to see how this new wound closure process affects your quality of life.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Tertiary Wound Closure
  • Procedure: Historical Wound Closure
N/A

Detailed Description

Primary Objective

To compare the percentage of patients whose wound remained closed on postoperative day #30 after tertiary closure compared to historical controls who underwent secondary would closure. We are primarily looking at time to wound closure. We will be able to abstract this information from the postoperative clinic visit notes from patients in the "historical control" cohort. We will identify 20 patients with characteristics described in the inclusion criteria of this study who underwent laparotomy with secondary would closure during the calendar year 2018.

Secondary Objectives

To compare the proportion of acute and chronic wound infection in wounds closed with a tertiary closure technique to historical controls receiving a secondary wound closure.

To compare the length of stay of patients receiving a tertiary wound closure to historical controls receiving a secondary wound closure.

To describe the number of patients receiving a tertiary wound closure that return within 30 days of surgery as compared to historical controls receiving a secondary wound closure.

To describe the quality of life in patients receiving a tertiary wound closure.

Study Design

Study Type:
Interventional
Actual Enrollment :
8 participants
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Secondary Versus Tertiary Wound Closure in High Risk Gynecologic Abdominal Surgical Incisions
Actual Study Start Date :
Feb 27, 2019
Actual Primary Completion Date :
Nov 26, 2020
Actual Study Completion Date :
Nov 26, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: Tertiary Wound Closure

In the alternative tertiary wound closure, the wound will be partially closed rather than being left open. Sutures in the skin will be placed but not closed. A vacuum assisted closure device will be placed over the wound to help healing. After 4-7 days, the vacuum device will be removed, and the participant's doctor will close the wound.

Procedure: Tertiary Wound Closure
The wound will be closed with what is considered tertiary wound closure. This means, rather than leaving the wound open, the wound will be partially closed after surgery, and then completely closed 4-7 days after surgery.

Active Comparator: Historical Wound Closure

The standard approach to your wound would be to leave it partially open and let it heal over a period of 3-6 months ("secondary closure").

Procedure: Historical Wound Closure
Participants wounds are left partially open to heal.

Outcome Measures

Primary Outcome Measures

  1. Percentage Comparisons of Tertiary Wound Closure Versus Historical Controls Postoperative Day 30 [30 days after tertiary wound closure]

    The percent of wound closure that occurs postoperative day #30 after tertiary wound closure as compared to historical controls receiving a secondary wound closure.

Secondary Outcome Measures

  1. Proportions of Tertiary Technique Versus Historical Controls [30 days after tertiary wound closure]

    The proportion of SSI using a tertiary closure technique compared to historical controls receiving a secondary would closure.

  2. Length of Hospital Stay [Up to 3 months after surgery]

    The length of stay as defined by the time from surgery to discharge as compared to historical controls receiving a secondary would closure.

  3. Proportion of Patients Returning after Surgery [Up to 30 days after surgery]

    The proportion of patients that return within 30 days of surgery.

  4. Change of Quality of Life Questionnaire SF-36 [Up to 3 months after tertiary wound closure]

    The quality of life in patients receiving a tertiary wound closure. The scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 65 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients with high risk class II, class III, class IV abdominal wounds

  • Undergoing laparotomy for gynecologic related disorders

  • Patients undergoing laparotomy for both benign and malignant diagnoses will be included in this study

Exclusion Criteria:
  • Pregnancy

  • Allergy to triclosan

  • Patients undergoing HIPEC

Contacts and Locations

Locations

Site City State Country Postal Code
1 Comprehensive Cancer Center of Wake Forest University Winston-Salem North Carolina United States 27157

Sponsors and Collaborators

  • Wake Forest University Health Sciences
  • National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Michael G Kelly, MD, Wake Forest University Health Sciences

Study Documents (Full-Text)

More Information

Publications

None provided.
Responsible Party:
Wake Forest University Health Sciences
ClinicalTrials.gov Identifier:
NCT03861065
Other Study ID Numbers:
  • IRB00055298
  • NCI-2019-01292
  • P30CA012197
  • CCCWFU04418
First Posted:
Mar 4, 2019
Last Update Posted:
Aug 10, 2022
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 10, 2022